Cellular mechanisms in mitral valve disease
- PMID: 21892743
- DOI: 10.1007/s12265-011-9318-7
Cellular mechanisms in mitral valve disease
Abstract
The mitral valve is a living structure comprised of specific structural components which contain a heterogeneous population of cells. The cells include an amalgam of interstitial cells within the valve and a continuous covering of endothelial cells, each of which play a role in responding to the mechanical forces that the valve experiences, to maintain the function and durability of the valve. Attention on the characteristics and function of valve cells has focused mainly on those in the aortic valve, with relatively few studies addressing the role of these cells in the physiological and pathophysiological function of the mitral valve. This article reviews what is known about the function of cells within the mitral valve and how the changes in the physical and chemical environments can affect their function in the different types of mitral valve disease. Investigating the contribution of the cellular components of the mitral valve to valve function in health and disease will aid the understanding of how the durability and function of the valve are regulated, and possibly highlight molecular and pharmacological targets for the development of novel treatments for mitral valve disease.
Similar articles
-
Progenitor cells confer plasticity to cardiac valve endothelium.J Cardiovasc Transl Res. 2011 Dec;4(6):710-9. doi: 10.1007/s12265-011-9312-0. Epub 2011 Jul 26. J Cardiovasc Transl Res. 2011. PMID: 21789724 Review.
-
Fibrous skeleton reconstruction for invasive aortic and mitral valve endocarditis.Asian Cardiovasc Thorac Ann. 2020 Sep;28(7):381-383. doi: 10.1177/0218492320957121. Asian Cardiovasc Thorac Ann. 2020. PMID: 33023307
-
The clinical anatomy of the mitral valve.Clin Anat. 2009 Jan;22(1):85-98. doi: 10.1002/ca.20692. Clin Anat. 2009. PMID: 18773480 Review.
-
Mitral valve annulus tension and the mechanism of annular dilation: an in-vitro study.J Heart Valve Dis. 2010 Nov;19(6):701-7. J Heart Valve Dis. 2010. PMID: 21214092
-
Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies.EuroIntervention. 2018 Mar 20;13(16):1889-1898. doi: 10.4244/EIJ-D-17-00704. EuroIntervention. 2018. PMID: 29260723
Cited by
-
The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration.Front Cardiovasc Med. 2022 May 17;9:872288. doi: 10.3389/fcvm.2022.872288. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35656405 Free PMC article.
-
The mechanisms, diagnosis and management of mitral regurgitation in mitral valve prolapse and hypertrophic cardiomyopathy.Discoveries (Craiova). 2016 Jun 30;4(2):e61. doi: 10.15190/d.2016.8. Discoveries (Craiova). 2016. PMID: 32309580 Free PMC article. Review.
-
In Vitro Models of Cardiovascular Calcification.Biomedicines. 2024 Sep 23;12(9):2155. doi: 10.3390/biomedicines12092155. Biomedicines. 2024. PMID: 39335668 Free PMC article. Review.
-
Mechanisms and clinical consequences of vascular calcification.Front Endocrinol (Lausanne). 2012 Aug 6;3:95. doi: 10.3389/fendo.2012.00095. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 22888324 Free PMC article.
-
Telotristat ethyl reverses myxomatous changes in mice mitral valves.Front Cardiovasc Med. 2022 Aug 4;9:945672. doi: 10.3389/fcvm.2022.945672. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35990981 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical